Primary extraskeletal osteosarcoma of the retroperitoneum: a case report.
- 1Department of General Surgery, Affiliated Hospital of Hebei University, Baoding, China.
- 2Basic Research Key Laboratory of General Surgery for Digital Medicine, Affiliated Hospital of Hebei University, Baoding, China.
- 3Department of Dermatology, Affiliated Hospital of Hebei University, Baoding, China.
Abstract
Extraskeletal osteosarcoma arising in the retroperitoneum is exceedingly rare, and its osteoid-producing histology closely mimics dedifferentiated liposarcoma. A 33-year-old woman presented with a 1-month history of progressive abdominal distension. Imaging revealed a 15 cm right retroperitoneal mass with punctate calcifications, no macroscopic fat, and no bone attachment. The mass was resected completely en bloc with negative microscopic margins (R0). Sections showed a high-grade sarcoma weaving through lace-like osteoid. MDM2 immunohistochemistry was negative and fluorescence in situ hybridization (FISH) detected no MDM2 amplification; CDK4 immunostaining and CDK4 FISH were likewise negative. No well-differentiated liposarcoma component was found on gross or microscopic examination, and together these findings ruled out 12q13-15 amplification. The final diagnosis was primary, high-grade extraskeletal osteosarcoma of the retroperitoneum. The patient received adjuvant MAP chemotherapy (methotrexate, doxorubicin, cisplatin) and at 25 months after surgery remains free of recurrence or metastasis; surveillance imaging will continue for at least 10 years. Any osteoid-producing retroperitoneal sarcoma without a well-differentiated liposarcoma component should undergo MDM2 amplification testing, and ideally CDK4 testing, because the two diagnoses are managed differently.
Related
- Chondroblastic osteosarcoma of the rib as a second primary malignancy following neuroblastoma: a case report.
- CT and MRI imaging features of atypical spindle cell lipomatous tumor in the retroperitoneum: a case report
- Spontaneous Pneumothorax During Stereotactic Body Radiotherapy for Pulmonary Metastasis From Osteosarcoma: A Case Report and Literature Review
- Multidisciplinary approach with stereotactic reirradiation to oligoprogressive spinal metastases from dedifferentiated osteosarcoma: a case report
- Temporal Bone Osteosarcoma in Pregnancy: A Case Report and Literature Review.
BibTeX
@article{ren2026primary,
title = {{Primary extraskeletal osteosarcoma of the retroperitoneum: a case report.}},
author = {Xiangxiang Ren and Tianhao Xie and Linqian Li and Xiaoshi Jin and Meng Zhang},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1921181},
url = {https://europepmc.org/article/MED/42923544},
note = {CC BY},
}
RIS
TY - JOUR
TI - Primary extraskeletal osteosarcoma of the retroperitoneum: a case report.
AU - Xiangxiang Ren
AU - Tianhao Xie
AU - Linqian Li
AU - Xiaoshi Jin
AU - Meng Zhang
PY - 2026
DA - 2026/10/08
JO - Frontiers in medicine
DO - 10.3389/fmed.2026.1921181
UR - https://europepmc.org/article/MED/42923544
AB - Extraskeletal osteosarcoma arising in the retroperitoneum is exceedingly rare, and its osteoid-producing histology closely mimics dedifferentiated liposarcoma. A 33-year-old woman presented with a 1-month history of progressive abdominal distension. Imaging revealed a 15 cm right retroperitoneal mass with punctate calcifications, no macroscopic fat, and no bone attachment. The mass was resected completely en bloc with negative microscopic margins (R0). Sections showed a high-grade sarcoma weaving through lace-like osteoid. MDM2 immunohistochemistry was negative and fluorescence in situ hybridization (FISH) detected no MDM2 amplification; CDK4 immunostaining and CDK4 FISH were likewise negative. No well-differentiated liposarcoma component was found on gross or microscopic examination, and together these findings ruled out 12q13-15 amplification. The final diagnosis was primary, high-grade extraskeletal osteosarcoma of the retroperitoneum. The patient received adjuvant MAP chemotherapy (methotrexate, doxorubicin, cisplatin) and at 25 months after surgery remains free of recurrence or metastasis; surveillance imaging will continue for at least 10 years. Any osteoid-producing retroperitoneal sarcoma without a well-differentiated liposarcoma component should undergo MDM2 amplification testing, and ideally CDK4 testing, because the two diagnoses are managed differently.
SN - 2296-858X
ER -